Clinical Study of the CardioFocus Endoscopic Ablation System for the Treatment of Symptomatic AF

Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (CFEAS- AC) for the Treatment of Symptomatic Atrial Fibrillation

The purpose of this study is to determine the safety and effectiveness of the endoscopic ablation system - adaptive contact (EAS-AC) in treated paroxysmal atrial fibrillation (PAF) with pulmonary vein isolation (PVI).

Inclusion Criteria:

• Symptomatic, Paroxysmal atrial fibrillation (AF)
• 18 to 70 years of age
• Failure of at least one AAD
• Others

Exclusion Criteria:

• Generally good overall health as determined by multiple criteria
• Willing to participate in a study
• Others